Active Ingredient	Balsalazide
Manufacturer	Intas Pharmaceuticals Ltd.
Origin	India
Other Names	N/A
Reference	N/A

What is Intazide (Balsalazide) used for?

Intazide (Balsalazide) inhibits the actions of the chemicals in the body which cause inflammation of the colon. It is used to treat ulcerative colitis and Crohn's disease. This drug is effective in relieving symptoms such as bleeding of the rectum, stomach pain and diarrhea.

How should I use Intazide (Balsalazide)?

Intazide (Balsalazide) tablets should be taken by mouth, and swallowed whole with a glass of water. You should follow the instructions of your physician, and only take the amount prescribed to you. Adult patients are sometimes told to take this drug 3 times per day. It is normally taken for a period of 8 weeks, however, your physician may tell you to take it for a longer period of time, sometimes as long as 12 weeks. Follow all instructions provided to you by your physician.

What are the side effects of Intazide (Balsalazide)?

Side effects of Intazide (Balsalazide) include:

• Abdominal pain or stomach upset
• Dry mouth
• Loss of appetite
• Muscular pain or back pain
• Infection of the urinary tract

If you notice any side effects while you are taking this medication, you should immediately consult your physician.

Please Note

Strictly follow all instructions provided to you by your physician or pharmacist while using Intazide (Balsalazide). Optimum and safe dosage can differ based on the patient and the condition being treated.

As this medication may be unsafe for certain patients, it is essential you always inform your physician if you are pregnant or breastfeeding, as well as if you have any allergies, other illnesses, or ongoing health conditions, and if you are taking any other form of medication, supplements, or herbal products.

Immediately seek emergency medical care if you have any allergic or hypersensitive reaction. Common signs of a reaction include hives, swelling, skin rashes, chest pains, as well as trouble breathing or swallowing.